Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and unsafe practices related to the promotion of knockoff versions of Wegovy, which may jeopardize its collaboration with Novo Nordisk [3][4]. Group 1: Allegations and Class Period - The class period for the lawsuit is from April 29, 2025, to June 23, 2025 [3]. - Allegations include that Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy, risking patient safety [3]. - The lawsuit claims that the company's positive statements about its business and prospects were materially misleading and lacked a reasonable basis [3]. Group 2: Shareholder Actions - Shareholders who purchased HIMS shares during the class period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of August 25, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm's Role - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders